Application | Comment | Organism |
---|---|---|
medicine | sEH enzyme gains considerable attention as a therapeutic target for cardiovascular diseases | Homo sapiens |
Inhibitors | Comment | Organism | Structure |
---|---|---|---|
1-(1-methanesulfonyl-piperidin-4-yl)-3-(4-trifluoromethoxy-phenyl)-urea | i.e. TUPS | Homo sapiens | |
1-(1-methanesulfonyl-piperidin-4-yl)-3-(4-trifluoromethoxy-phenyl)-urea | i.e. TUPS | Mus musculus | |
1-(1-nicotinoylpiperidin-4-yl)-3-(4-(trifluoromethoxy)phenyl)-urea | i.e. AR9276 | Homo sapiens | |
1-(1-nicotinoylpiperidin-4-yl)-3-(4-(trifluoromethoxy)phenyl)-urea | i.e. AR9276 | Mus musculus | |
1-adamantanyl-3-(5-(2-(2-ethoxyethoxy)ethoxy)pentyl)urea | i.e. AEPU | Homo sapiens | |
1-adamantanyl-3-(5-(2-(2-ethoxyethoxy)ethoxy)pentyl)urea | i.e. AEPU | Mus musculus | |
1-cyclohexyl-3-dodecyl urea | i.e. CDU | Homo sapiens | |
1-cyclohexyl-3-dodecyl urea | i.e. CDU | Mus musculus | |
1-trifluoromethoxyphenyl-3-(1-acetylpiperidin-4-yl) urea | i.e. TPAU | Homo sapiens | |
1-trifluoromethoxyphenyl-3-(1-acetylpiperidin-4-yl) urea | i.e. TPAU | Mus musculus | |
12-(3-adamantan-1-yl-ureido)-dodecanoic acid | i.e. AUDA | Homo sapiens | |
12-(3-adamantan-1-yl-ureido)-dodecanoic acid butyl ester | i.e. AUDA-BE | Homo sapiens | |
12-(3-adamantan-1-yl-ureido)-dodecanoic acid butylester | i.e. AUDA-BE | Mus musculus | |
additional information | sEH inhibition has antihypertensive and antiinflammatory actions, presumably due to the increased bioavailability of endogenous EETs and other epoxylipids, and several potent sEH inhibitors are developed and tested in animal models of cardiovascular disease including hypertension, cardiac hypertrophy, and ischemia/reperfusion injury | Homo sapiens | |
trans-4-(4-(3-adamantan-1-yl-ureido)-cyclohexyloxy)-benzoic acid | i.e. t-AUCB | Homo sapiens | |
trans-4-(4-(3-adamantan-1-yl-ureido)-cyclohexyloxy)-benzoic acid | i.e. t-AUCB | Mus musculus |
Localization | Comment | Organism | GeneOntology No. | Textmining |
---|---|---|---|---|
cytosol | - |
Homo sapiens | 5829 | - |
cytosol | - |
Mus musculus | 5829 | - |
peroxisome | - |
Homo sapiens | 5777 | - |
peroxisome | - |
Mus musculus | 5777 | - |
soluble | - |
Homo sapiens | - |
- |
soluble | - |
Mus musculus | - |
- |
Molecular Weight [Da] | Molecular Weight Maximum [Da] | Comment | Organism |
---|---|---|---|
62000 | - |
2 * 62000 | Homo sapiens |
62000 | - |
2 * 62000 | Mus musculus |
Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|
additional information | Homo sapiens | soluble epoxide hydrolase is an enzyme that catalyzes the hydrolysis of epoxyeicosatrienoic acids, EETs, which are lipid mediators derived from arachidonic acid through the cytochrome P450 epoxygenase pathway. EETs can activate multiple antiapoptotic targets through PI3K/Akt survival signaling and protect cardiomyocytes from hypoxia/anoxia | ? | - |
? | |
additional information | Mus musculus | soluble epoxide hydrolase is an enzyme that catalyzes the hydrolysis of epoxyeicosatrienoic acids, EETs, which are lipid mediators derived from arachidonic acid through the cytochrome P450 epoxygenase pathway. EETs can activate multiple antiapoptotic targets through PI3K/Akt survival signaling and protect cardiomyocytes from hypoxia/anoxia | ? | - |
? |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | - |
- |
- |
Mus musculus | P34914 | - |
- |
Reaction | Comment | Organism | Reaction ID |
---|---|---|---|
an epoxide + H2O = a glycol | the catalytic mechanism involves two step processes, overview | Homo sapiens | |
an epoxide + H2O = a glycol | the catalytic mechanism involves two step processes, overview | Mus musculus |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
heart | - |
Homo sapiens | - |
heart | - |
Mus musculus | - |
kidney | - |
Homo sapiens | - |
kidney | - |
Mus musculus | - |
liver | - |
Homo sapiens | - |
liver | - |
Mus musculus | - |
myocyte | high level of expression of sEH in atrial and ventricular myocytes | Mus musculus | - |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
additional information | soluble epoxide hydrolase is an enzyme that catalyzes the hydrolysis of epoxyeicosatrienoic acids, EETs, which are lipid mediators derived from arachidonic acid through the cytochrome P450 epoxygenase pathway. EETs can activate multiple antiapoptotic targets through PI3K/Akt survival signaling and protect cardiomyocytes from hypoxia/anoxia | Homo sapiens | ? | - |
? | |
additional information | soluble epoxide hydrolase is an enzyme that catalyzes the hydrolysis of epoxyeicosatrienoic acids, EETs, which are lipid mediators derived from arachidonic acid through the cytochrome P450 epoxygenase pathway. EETs can activate multiple antiapoptotic targets through PI3K/Akt survival signaling and protect cardiomyocytes from hypoxia/anoxia | Mus musculus | ? | - |
? | |
additional information | each monomer is comprised of two distinct structural domains, linked by a proline-rich segment, the 35 kDa C-terminal domain displays epoxide hydrolase activity, while the N-terminal domain exhibits phosphatase activity | Homo sapiens | ? | - |
? | |
additional information | each monomer is comprised of two distinct structural domains, linked by a proline-rich segment, the 35 kDa C-terminal domain displays epoxide hydrolase activity, while the N-terminal domain exhibits phosphatase activity | Mus musculus | ? | - |
? |
Subunits | Comment | Organism |
---|---|---|
homodimer | 2 * 62000 | Homo sapiens |
homodimer | 2 * 62000 | Mus musculus |
More | each monomer is comprised of two distinct structural domains, linked by a proline-rich segment, the 35 kDa C-terminal domain displays epoxide hydrolase activity, while the N-terminal domain exhibits phosphatase activity | Homo sapiens |
More | each monomer is comprised of two distinct structural domains, linked by a proline-rich segment, the 35 kDa C-terminal domain displays epoxide hydrolase activity, while the N-terminal domain exhibits phosphatase activity | Mus musculus |
Synonyms | Comment | Organism |
---|---|---|
SEH | - |
Homo sapiens |
SEH | - |
Mus musculus |
Organism | Comment | Expression |
---|---|---|
Homo sapiens | pharmacological induction of sEH by exposure to peroxisome-proliferating activated receptor alpha ligands like clofibrate, tiadenol, or acetylsalicylic acid | up |
General Information | Comment | Organism |
---|---|---|
malfunction | sEH inhibitor treatment is effectively preventing pressure overload- and angiotensin II-induced cardiac hypertrophy and reverses the pre-established cardiac hypertrophy caused by chronic pressure overload, overview | Homo sapiens |
malfunction | treatment of apolipoprotein E-deficient mice with sEH inhibitors significantly attenuates atherosclerosis development and abdominal aortic aneurysm formation | Mus musculus |
additional information | cardioprotective roles of sEH inhibition in myocardial ischemia-reperfusion injury | Homo sapiens |
additional information | cardioprotective roles of sEH inhibition in myocardial ischemia-reperfusion injury | Mus musculus |